This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Monika Kanter: Innovator in Pharmaceutical Compositions
Introduction
Monika Kanter is a notable inventor based in Saarburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug stability and efficacy. With a total of 2 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Kanter's latest patents include a groundbreaking pharmaceutical composition comprising clevidipine in a sterile, ready-to-use, physically stable, aqueous dispersion of nanoparticles. This formulation stabilizes clevidipine against the formation of impurities and is suitable for parenteral administration. Her innovative approach addresses critical challenges in drug delivery and stability.
Career Highlights
Monika Kanter is currently associated with Chiesi Farmaceutici S.p.A., where she continues to push the boundaries of pharmaceutical research. Her expertise in nanoparticle technology has positioned her as a key player in the development of advanced therapeutic solutions.
Collaborations
Throughout her career, Kanter has collaborated with esteemed colleagues, including Rajeshwar Motheram and Akif Emre Tureli. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their projects.
Conclusion
Monika Kanter's contributions to pharmaceutical innovations exemplify her dedication to improving drug formulations and patient care. Her work not only highlights her inventive spirit but also underscores the importance of collaboration in advancing medical science.